HEPMET-1: Evaluate the Feasibility, Mental Sideeffects and the Efficacy of Hepatitis C Treatment in a MMT Group.

NCT00147784 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

10

Enrollment

OTHER_GOV

Sponsor class

Conditions

Opiate Dependence
Hepatitis

Interventions

DRUG: Ribavirin
DRUG: Pegylated Interferon

Sponsor

Sorlandet Hospital HF